-
-
-
-
-
-
-
Valent BioSciences Announces the Acquisition of FBSciences
-
-
-
-
-
-
-
Myovant Sciences Announces Further Financing Support from Sumitomo Dainippon Pharma and Commercial Collaboration with Sunovion Pharmaceuticals
-
-
-
-
-
-
-
Sumitovant Biopharma Created and Launched as Sumitomo Dainippon Pharma and Roivant Sciences Close Transaction for Strategic Alliance
-
-
-
-
-
-
-
Myovant Sciences Enters Landmark Agreement with Sumitomo Dainippon Pharma to Secure Major Financial Backing and Safeguards for Minority Shareholders
-
-
-
-
-
-
-
Sunovion Highlights Data from Its Psychiatry Portfolio at the 2019 American Psychiatric Association Annual Meeting
-
-
-
-
-
-
-
Sunovion Announces Health Canada Acceptance of New Drug Submission for Apomorphine Sublingual Film (APL-130277)
-
-
-
-
-
-
-
Sunovion to Deliver Multiple Presentations at the 2018 American Psychiatric Association Annual Meeting
-
1,122,779 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

